Non-Invasive Aesthetic Treatment Market Report 2025

The non-invasive aesthetic treatment market size has grown rapidly in recent years. It will grow from $66.52 billion in 2024 to $77.25 billion in 2025 at a compound annual growth rate (CAGR) of 16.1%. The growth in the historic period can be attributed to cultural shifts, changing demographics, medical advancements, media and influencers, pioneering treatments, shifting beauty ideals.

The non-invasive aesthetic treatment market size is expected to see rapid growth in the next few years. It will grow to $139.02 billion in 2029 at a compound annual growth rate (CAGR) of 15.8%. The growth in the forecast period can be attributed to health and wellness trends, emerging markets' influence, expansion of men's market, global aging population, advancements in personalization. Major trends in the forecast period include growing demand for minimally invasive procedures, consumer awareness and education, celebrity endorsements and influencer culture, customization and personalization.

The growing emphasis on physical appearance among adults is set to drive the expansion of the non-invasive aesthetic treatment market. Physical appearance encompasses the external aspect of an individual, independent of factors such as gender, weight, or height. With a rapid increase in self-consciousness, individuals are increasingly investing in products and medical treatments to enhance their external appearance. For instance, as reported by L'Oréal S.A. in February 2023, a France-based personal care products company, sales of consumer products experienced a notable increase from 11.8% to 14.6%, and active cosmetics sales rose from 28% to 30.6% from the 3rd quarter of 2022 to the 4th quarter of 2022. This data underscores the growing focus on physical appearance and the associated surge in demand for non-invasive aesthetic treatments, reflecting a consumer preference for enhancing their external features during the forecast period.

The rising number of cosmetic surgeries is expected to drive the growth of the non-invasive aesthetic treatment market in the future. Cosmetic surgery, often referred to as aesthetic surgery, encompasses a range of surgical and non-surgical procedures aimed at enhancing an individual's appearance. Non-invasive aesthetic treatments are utilized in cosmetic surgeries as a less invasive and often more affordable alternative, employing various technologies to address concerns such as wrinkles, fine lines, uneven skin tone, and sagging skin. For example, in September 2023, the International Society of Aesthetic Plastic Surgery (ISAPS), a U.S.-based organization dedicated to the education and advancement of aesthetic plastic surgery, reported an overall increase of 11.2% in procedures performed by plastic surgeons in 2022, totaling over 14.9 million surgical and 18.8 million non-surgical treatments. Thus, the growing number of cosmetic surgeries is propelling the growth of the non-invasive aesthetic treatment market.

Leading companies in the non-invasive aesthetic treatment market are actively engaged in the development of innovative products, with a notable example being the introduction of picosecond lasers to gain a competitive edge. Picosecond lasers are a specific type of laser that emits extremely short-duration pulses of light, typically ranging between 1 picosecond (ps) and 100 ps. In June 2022, Cynosure, a US-based manufacturer specializing in light-based aesthetic and medical treatments, launched the PicoSure Pro device. This represents an upgraded version of the PicoSure system, distinguished as the first and only FDA-cleared 755nm picosecond laser available on the market. The PicoSure Pro device delivers energy in a trillionth of a second, utilizing pressure instead of heat to provide safe and effective treatments for unwanted pigmentation and skin revitalization across all skin types. This innovative device offers practitioners enhanced flexibility compared to previous models, enabling them to treat a higher number of patients per day and achieve superior outcomes in less time. This strategic introduction of advanced technologies exemplifies the industry's commitment to staying competitive and meeting the evolving demands of the non-invasive aesthetic treatment market.

Prominent companies in the non-invasive aesthetic treatment market are actively engaging in strategic partnerships to foster product development and fortify their positions in the industry. These collaborations play a crucial role in driving innovation, expediting research and development, expanding market access, and enhancing overall credibility, contributing to a comprehensive and dynamic advancement of the market. A case in point is the partnership forged in August 2023 between BeautyHealth, a US-based category-creating company, and LaserAway, a US-based provider of laser hair removal and aesthetic treatments. This collaboration aims to integrate patented vortex fusion technology with a digital experience, providing increased accessibility to Hydrafacial treatments for consumers while offering valuable data insights for both companies. Such strategic alliances underscore the commitment of major players to leverage collective strengths and resources for mutual growth and innovation in the non-invasive aesthetic treatment market.

In January 2022, Galderma, a Switzerland-based company renowned for its expertise in dermatological treatments and skincare products, successfully acquired ALASTIN Skincare Inc for an undisclosed sum. This strategic move by Galderma is geared towards fortifying its product portfolio within the premium segment and augmenting research and development initiatives in the field of dermatology. ALASTIN Skincare Inc., a USA-based entity recognized for its clinically tested skincare products, aligns seamlessly with Galderma's strategic objectives and contributes to the company's commitment to advancing innovation in dermatological care.

Major companies operating in the non-invasive aesthetic treatment market include Johnson & Johnson, Allergen, BTL Industries, Bausch Health Companies Inc., Hologic Inc., Cynosure LLC, Galderma S.A., MerzPharma, Sinclair Pharma, InMode Ltd., Lumenis, ZELTIQ Aesthetics Inc., Solta Medical, Syneron Medical Ltd., Cutera Inc., Lutronic Corporation, Revance Therapeutics Inc., Venus Concept, Fotona d.o.o., Sientra Inc., EndyMed Medical Ltd., Alma Lasers, Sciton Inc., ThermiGen LLC, Candela Corporation.

North America was the largest region in the non-invasive aesthetic treatment market in 2024. The Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the non-invasive aesthetic treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the non-invasive aesthetic treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Non-invasive aesthetic treatment refers to products used in cosmetic medical procedures that avoid the need for surgery or incisions. These treatments are typically painless or involve minimal and temporary discomfort, offering the advantage of minimal downtime and a low risk of complications.

The primary categories of non-invasive aesthetic treatments include injectables and skin rejuvenation. Aesthetic injectables comprise products administered through injections to smooth, remodel, or augment facial areas, encompassing treatments such as wrinkle relaxers or dermal fillers. These treatments find usage in hospitals and surgery centers, medical spas, clinics, traditional spas, and healthcare provider (HCP)-owned clinics.

The non-invasive aesthetic treatment market research report is one of a series of new reports that provides non-invasive aesthetic treatment market statistics, including non-invasive aesthetic treatment industry global market size, regional shares, competitors with a non-invasive aesthetic treatment market share, detailed non-invasive aesthetic treatment market segments, market trends and opportunities, and any further data you may need to thrive in the non-invasive aesthetic treatment industry. This non-invasive aesthetic treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The non-invasive aesthetic treatment market includes revenues earned by entities by microblading, neurotoxin injections, dermal fillers, latisse, non-surgical fat removal, chemical peels and laser hair removal. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.